SCHEMBL6946094

SCHEMBL6946094

CC(N)SP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9231975 0.76 LAP3 (0.39)
SCHEMBL2430320 0.75
SCHEMBL18042445 0.73
SCHEMBL2148521 0.72 LAP3 (0.36)
SCHEMBL5054821 0.70
Phosphoric Acid SCHEMBL10804224 0.70
Phosphoric Acid SCHEMBL30622468 0.70
SCHEMBL242135 0.67
Phosphoric Acid SCHEMBL1831540 0.67
SCHEMBL6257829 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1039887-A4 METHODS FOR TREATMENT OF NEURO- AND NEPHRO-DISORDERS AND THERAPEUTIC TOXICITIES USING AMINOTHIOL COMPOUNDS MEDIMMUNE ONCOLOGY INC (US) 2003-01-15 EP disclosed
EP-1039887-A1 METHODS FOR TREATMENT OF NEURO- AND NEPHRO-DISORDERS AND THERAPEUTIC TOXICITIES USING AMINOTHIOL COMPOUNDS U.S. BIOSCIENCE, INC. (US) 2000-10-04 EP disclosed
WO-1999029312-A1 METHODS FOR TREATMENT OF NEURO- AND NEPHRO-DISORDERS AND THERAPEUTIC TOXICITIES USING AMINOTHIOL COMPOUNDS U.S. BIOSCIENCE, INC. (US) 1999-06-17 WO disclosed